GlassScriptPhysician profile
Sara V Mccarthy
NPI 1336542075
$3,908.66
in general payments reported to CMS, 2019-2025
21 companies · $501 in 2025
The $501 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,208 · 2022: $882 · 2023: $681 · 2024: $637 · 2025: $501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806 · Education: $12.82.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.99 |
| Education | $12.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,130.42 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $618.99 | 2021-2025 | Trintellix |
| Vanda Pharmaceuticals INC. | $462.85 | 2021-2025 | Fanapt, Hetlioz |
| Axsome Therapeutics, INC. | $424.67 | 2022-2025 | Auvelity, Sunosi |
| Otsuka America Pharmaceutical, INC. | $314.18 | 2021-2025 | Rexulti, Nuedexta |
| Bausch Health US, LLC | $260.88 | 2021-2025 | Aplenzin, Wellbutrin |
| Lundbeck LLC | $121.48 | 2021-2023 | Rexulti |
| Avanir Pharmaceuticals, INC. | $84.82 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $82.62 | 2022 | |
| Boston Scientific Corporation | $80.79 | 2023 | Infinion 16 |
| Idorsia Pharmaceuticals US INC | $61.98 | 2023-2024 | Quviviq |
| Alkermes, INC. | $47.71 | 2022-2023 | Aristada, Lybalvi |
| Scilex Pharmaceuticals INC. | $41.95 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.21 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $34.34 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $22.91 | 2025 | Senza |
| E.R. Squibb & Sons, L.L.C. | $22.46 | 2025 | Cobenfy |
| Redhill Biopharma INC. | $15.87 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.96 | 2021 | |
| Almatica Pharma LLC | $13.39 | 2022 | |
| Spr Therapeutics, INC | $13.18 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.